49.42 +0.22 (0.45%)
After hours: 4:11PM EDT
|Bid||45.70 x 900|
|Ask||55.00 x 800|
|Day's range||48.60 - 50.00|
|52-week range||3.05 - 50.75|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||34.71|
Wall Street cheers after the company announced favorable terms from a just-announced capital raise. Here's what investors need to know.
On a per-share basis, the San Diego-based company said it had a loss of 51 cents. The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...
Biotechnology stocks dominate our list of top charts to watch, with a uranium producer also advancing to the list. CASI Pharmaceuticals Inc.(CASI) rose 48 cents, or 7.2%, to $7.14 on 773,700 shares traded Tuesday. The move came on no news from the company, although the stock soared in early April on news that China’s Food and Drug Administration (CFDA) would convene a panel to discuss its cancer therapy, Evomela.
The San Diego-based company said it had a loss of 65 cents per share. The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for ...